FDA Drug Recalls

Recalls / Class III

Class IIID-576-2013

Product

Lamisil AT Cream (terbinafine hydrochloride 1% antifungal), 12 gm ( .42 oz) Tubes and 30 gm (1 oz) Tubes packaged in one box, Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300676249438. (Club Pack), NDC 0067-6295-43

Affected lot / code info
Lot #: 10109590, 10111050, Exp 2/28/13.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.

Recalling firm

Firm
Novartis Consumer Health
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
10401 Hwy 6, N/A, Lincoln, Nebraska 68517-9626

Distribution

Quantity
41,400 Boxes
Distribution pattern
Nationwide and Puerto Rico, and Panama. Military distribution made.

Timeline

Recall initiated
2013-02-19
FDA classified
2013-06-06
Posted by FDA
2013-06-12
Terminated
2014-11-26
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-576-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls